Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-25-000738
Filing Date
2025-08-12
Accepted
2025-08-12 13:00:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12356
2 JOINT FILING AGREEMENT ss5199065_ex99a.htm EX-99.A 6747
3 ss5199065_ex99b.htm EX-99.B 2794
  Complete submission text file 0000947871-25-000738.txt   23823
Mailing Address 450 PARK AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 450 PARK AVENUE 20TH FLOOR NEW YORK NY 10022 2124154600
STEADFAST CAPITAL MANAGEMENT LP (Filed by) CIK: 0001214822 (see all company filings)

EIN.: 030481537 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Subject) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-90013 | Film No.: 251205627
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)